LACTOBACILLEMIA - REPORT OF 9 CASES - IMPORTANT CLINICAL AND THERAPEUTIC CONSIDERATIONS
LACTOBACILLEMIA - REPORT OF 9 CASES - IMPORTANT CLINICAL AND THERAPEUTIC CONSIDERATIONS
复制标题
DOI:
10.1016/0002-9343(78)90521-1
复制
发表时间:
1978-01-01
影响因子:
5.9
通讯作者:
GUZE, LB
中科院分区:
文献类型:
--
作者:
BAYER, AS;CHOW, AW;GUZE, LB
Serious infections due to lactobacilli have been rarely cited. Findings in 9 recent patients with lactobacillemia are reported. In the combined literature and current experience, endocarditis and sepsis from localized suppuration were the most common clinical syndromes, most frequently arising from prior oropharyngeal infections. Lactobacillus endocarditis showed a predilection for left-sided cardiac involvement (100%) and systemic arterial embolization (55%). The 9 clinical isolates were tested for minimal inhibitory and bactericidal concentrations (MICs and MBCs) against 5 drugs with broad gram-positive spectrums; these organisms demonstrated a high incidence of unachievable MBCs (64%) and widely disparate (> 100 fold) MIC:MBC ratios (38%). This is in accord with observations in Lactobacillus endocarditis of poor in vivo clinical response despite appropriate regimens and achievable MICs of the organisms. Bactericidal synergistic studies on 2 endocarditis isolates indicated that the penicillins plus aminoglycosides may be potentially useful in the treatment of deep-seated Lactobacillus infections when single antimicrobials fail to achieve a cure.